特朗普总统宣布任命医学博士海蒂·欧弗顿为美国食品药品监督管理局(FDA)主管2。欧弗顿现任白宫国内政策委员会副主任，拥有新墨西哥大学医学学位和约翰霍普金斯大学临床研究博士学位12。在加入特朗普第二任期政府前，她曾任美国优先政策研究所首席政策官2。
特朗普在Truth Social上称欧弗顿是"聪慧受尊敬的摇滚明星"，表示她将推进更快的治愈、创新和降低药品价格2。卫生部长罗伯特·肯尼迪二世在X上表示支持，称她具有"非凡的判断力、专业精神、纪律性和对美国人民的坚定承诺"2。
这一提名立即引发争议。共和党参议员比尔·卡西迪表示对提名有"强烈关切"，称欧弗顿缺乏管理经验，参与最近的疫苗分离令"几乎不能胜任"2。民主党参议员帕蒂·默里批评她是"极右翼、反堕胎极端分子，不应领导FDA"2。欧弗顿曾在白宫活动中支持特朗普关于将麻腮风疫苗分离为三种单独疫苗的命令，尽管医疗专业组织反对这一举措2。
欧弗顿的任命需要获得参议院确认，她将面临平衡特朗普优先事项、肯尼迪的健康倡议以及共和党传统利益的挑战2。前任FDA主任玛蒂·马卡里已于5月辞职，留下关于超加工食品、抗抑郁药和COVID-19疫苗的未完成项目2。
President Donald Trump has selected Dr. Heidi Overton to serve as commissioner of the Food and Drug Administration, according to announcements made Wednesday.2 Overton holds a medical degree from the University of New Mexico and a doctorate in clinical research from Johns Hopkins University, and currently serves as deputy director of the White House Domestic Policy Council.12 Prior to joining the Trump administration's second term, she worked as chief policy officer at the American First Policy Institute.2
Trump described Overton on Truth Social as a "smart, respected rock star" who will advance faster cures, innovation, and lower drug prices.2 If confirmed by the Senate, Overton will face the challenge of balancing Trump's priorities, health initiatives championed by Health Secretary Robert F. Kennedy Jr., and traditional Republican interests.2 Kennedy voiced his support on X, calling Overton a person of "extraordinary judgment, professionalism, discipline, and steadfast commitment to the American people."2
However, the nomination has generated immediate controversy in the Senate. Republican Senator Bill Cassidy expressed "strong concerns" about Overton, citing her lack of management experience and suggesting her involvement in recent vaccine separation directives made her "almost unfit" for the role.2 Democratic Senator Patty Murray characterized Overton as an "extreme right-wing, anti-abortion extremist who should not lead the FDA."2 Overton previously supported Trump's directive to separate the MMR vaccine into three individual vaccines during White House discussions, a position opposed by major medical organizations.2
This appointment follows the May resignation of former FDA Director Marty Makary, who left unfinished agency initiatives on ultra-processed foods, antidepressants, and COVID-19 vaccines.2
评论
还没有评论，欢迎留下第一条。